Medindia
Medindia LOGIN REGISTER
Advertisement

Tagrisso® (osimertinib) receives full Health Canada approval for targeted treatment of non-small cell lung cancer

Wednesday, January 31, 2018 Cancer News
Advertisement

____________________________________1 TAGRISSO™ (osimertinib) Product Monograph. Accessed January 26, 2018: https://www.astrazeneca.ca/content/dam/az-ca/downloads/productinformation/tagrisso-product-monograph-en.pdf 

2 Lung Cancer Canada, The Faces of Lung Cancer Report 2017. Accessed January 26, 2018:  http://www.lungcancercanada.ca/LungCancerCanada/media/Documents/Faces-of-Lung-Cancer-Report-2017.pdf     

3 Molina JR, et al. Non-small cell lung cancer: Epidemiology, risk factors, treatment and survivorship. Mayo Clin Proc. 2008 May; 83(5): 584-594.

4 Ellison G, et al. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol. 2013; 66: 79-89.

Sponsored Post and Backlink Submission


Latest Press Release on Cancer News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close